Most of my research has involved costing or cost-effectiveness analyses to inform interventions for infectious diseases in the Asia-Pacific region. Some of these include mass drug administration for scabies, public health measures for COVID-19, molecular testing for malaria and arboviruses, and pneumococcal conjugate vaccines. I am mailny interested in improving methods in economic evaluation. I am also keen on assessing multicomponent interventions, conducting evaluations using real-world data, and creating user- friendly decision models.
-
Akpan E, Ku Abd Rahim KN, Devine A, Sharifa Ezat WP, Abraham P, Ali FZ, et al. “Health and economic burden of COVID-19 in Malaysia between January 2020 and December 2022..” Public Health. 2026; 250:105992. doi:
10.1016/j.puhe.2025.105992 -
Le TP, Conway E, Akpan E, Abell I, Abraham P, Baker CM, et al. “Health impact and cost-effectiveness of COVID-19 booster vaccination strategies in the early post-Omicron era: a dynamic modelling study.” BMJ Global Health. 2025; 2023. doi:
10.1136/bmjgh-2024-016096 -
Carvalho N, Jayasundara P, Abd Rahim KNK, Akpan E, Devine A, Hughes A, et al. “Epidemiologic and economic modelling of COVID-19 public health interventions in Malaysia during 2021 and 2022.” Melbourne Health Economics 2024. doi:
10.26188/28015307.v1 -
Akpan E, Thean LJ, Baskota R, Mani J, Mow M, Sahukhan A, et al. “Costs of primary healthcare presentations and hospital admissions for scabies and related skin infections in Fiji, 2018-2019.” PLOS Global Public Health. 2024; 4(10):e0003706. doi:
10.1371/journal.pgph.0003706 -
Akpan E, Hossain SJ, Devine A, Braat S, Hasan MI, Tipu SMMU, et al. “Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh.” American Journal of Clinical Nutrition. 2022; 116(5):123–140. doi:
10.1093/ajcn/nqac225